Skip to content

Pacific Biosciences

Recent events

Recent events tied to this brand in public sources.

Back to profile4 entries

  1. 2026

    PacBio and Verily Health begin strategic collaboration

    PacBio said it initiated a multi-year strategic collaboration with Verily Health to combine HiFi long-read data with real-world clinical data at population scale.

  2. 2026

    PacBio reports third-quarter 2026 financial results

    PacBio announced financial results for the quarter ended September 30, 2026, reporting revenue of $40.6 million and a GAAP net loss of $37.8 million.

  3. 2026

    PacBio appoints Mark Van Oene interim CFO

    PacBio said Jim Gibson had stepped down as CFO and appointed Mark Van Oene interim CFO while it searches for a new CFO.

  4. 2019

    PGI files patent infringement complaint against PacBio

    Personal Genomics Taiwan, Inc. (PGI) filed a complaint against Pacific Biosciences of California, Inc. (PacBio) in U.S. District Court, alleging that PacBio's Sequel and Sequel II products and related commercialization activities infringe claims of PGI's U.S. Patent No. 7,767,441.